Skip to main content

Table 2 The overall survival of 170 gastric cancer patients is analyzed after resection

From: The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression

 

Univariate analysis (N = 170)

Multivariate analysis (N = 170)

 

Endpoint status(%)

 

95% CI

 
 

Survival

Death

pvalue

Mean

Lower

Upper

pvalue

Gender

  

0.317

1.425

1.349

1.501

0.320

Male

51 (53.7)

44 (46.3)

     

Female

46 (61.3)

29 (38.7)

     

Age

  

0.440

64.797

62.673

66.92

0.718

≤50 years

17 (50.0)

17 (50.0)

     

>50 years

78 (57.4)

58 (43.6)

     

Tumor Location

  

0.566

2.494

2.372

2.617

0.991

Proximal

46 (58.2)

33 (41.8)

     

Distal

49 (53.8)

42 (46.2)

     

Tumor Size (cm)

  

0.011

4.632

4.208

5.507

0.006

≤5

72 (62.6)

43 (37.4)

     

>5

23 (41.8)

32 (58.2)

     

Lauren Classification

  

0.189

2.016

1.875

2.158

0.212

Intestinal

45 (61.6)

28 (38.4)

     

Diffuse

50 (51.5)

47 (48.5)

     

Tumor Stage

  

0.000

1.491

1.419

1.563

0.000

Early

65 (68.4)

25 (33.3)

     

Advance

30 (31.6)

50 (66.7)

     

LN Metastasis

  

0.000

0.584

0.512

0.656

0.000

No

55 (74.3)

19 (25.7)

     

Yes

40 (41.7)

56 (58.3)

     

OPN Staining

  

0.015

2.266

2.125

2.407

0.026

≤50%

52 (65.8)

27 (34.2)

     

>50%

43 (47.3)

48 (52.7)

     

CD204 Staining

  

0.034

2.304

2.169

2.439

0.049

≤50%

51

28

     

>50%

44

47

     

OPN vs. CD204 Staining

 

0.007

2.678

2.494

2.861

0.001

≤50% vs. ≤50%

36 (76.6)

11 (23.4)

     

≤50% vs. >50%

16 (53.3)

14 (46.7)

     

>50% vs. ≤50%

15 (50.0)

15 (50.0)

     

>50% vs. >50%

28 (44.4)

35 (55.6)

     
  1. Statistically significant p values are shown in bold.